Agios Pharmaceuticals
AGIO
AGIO
159 hedge funds and large institutions have $1.95B invested in Agios Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $2.81B → $1.95B (-$865M)
51% less call options, than puts
Call options by funds: $6.91M | Put options by funds: $14M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
159
Holding in Top 10
–
Calls
$6.91M
Puts
$14M
Top Buyers
| 1 | +$19.7M | |
| 2 | +$14.6M | |
| 3 | +$14.4M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.62M |
| 5 |
EHI
Eagle Health Investments
Greenwich,
Connecticut
|
+$6.44M |
Top Sellers
| 1 | -$46.5M | |
| 2 | -$42.7M | |
| 3 | -$37.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.4M |
| 5 |
BlackRock
New York
|
-$11.5M |